the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.
.
.
.